期刊
CHEMICAL COMMUNICATIONS
卷 56, 期 77, 页码 11473-11476出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/d0cc04728g
关键词
-
资金
- GSK-EDB Trust Fund [R-143-000-88-592]
- Synthetic Biology Research & Development Programme (SBP) of National Research Foundation of Singapore [SBP-P4, SBP-P8]
- National Natural Science Foundation of China [81672508]
A versatile strategy for the intracellular delivery of functional proteins/antibodies was developed using N-terminal site-specific modification. Adopting orthogonal dual-labeling strategies, a cell-permeable RNase A prodrug was designed complementing N-terminal site-specific modification with lysine labeling. Upon successful cytosolic uptake, the prodrug showed reactive oxygen species (ROS)-dependent targeted cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据